⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL31289366 | 0.91 | — | — | |
| Adamantane SCHEMBL21067465 | 0.84 | CYP2C9 (0.43) | — | |
| Adamantane SCHEMBL10877234 | 0.84 | CYP2C9 (0.43) | — | |
| Adamantane SCHEMBL19350269 | 0.84 | CYP2C9 (0.43) | — | |
| Adamantane SCHEMBL25252048 | 0.84 | CYP2C9 (0.43) | — | |
| Adamantane SCHEMBL25264306 | 0.84 | CYP2C9 (0.43) | — | |
| Adamantane SCHEMBL20741994 | 0.84 | CYP2C9 (0.43) | — | |
| Adamantane SCHEMBL21192802 | 0.84 | CYP2C9 (0.43) | — | |
| Adamantane SCHEMBL21820021 | 0.84 | CYP2C9 (0.43) | — | |
| Adamantane SCHEMBL1359892 | 0.84 | CYP2C9 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5306 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059864-A | Azido-containing seleno-ether compound, seleno-oxide, preparation methods and application | 福建师范大学 | 2026-05-19 | — | — | CN | claimed |
| CN-122010833-A | Method for catalyzing tension ring heteroaryl by iron | 南京师范大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4735447-A1 | AROMATIC NITROGEN-CONTAINING COMPOUNDS, PREPARATION METHODS AND MEDICINAL USES THEREOF | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) | 2026-05-06 | — | — | EP | claimed |
| EP-4727934-A1 | TREM2 AGONISTS | F. Hoffmann-La Roche AG (CH) | 2026-04-22 | — | — | EP | claimed |
| EP-3515892-B1 | COMPOUNDS AND METHODS FOR IDO AND TDO MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON INC (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4719421-A1 | COMBINATION THERAPY COMPRISING KIT INHIBITORS FOR USE IN THE TREATMENT OF CANCER | IDRX, INC. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4720036-A1 | CYP26B1 INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF | 16380026 Canada Inc. (CA) | 2026-04-08 | — | — | EP | claimed |
| EP-4720061-A1 | TREM2 AGONISTS | F. Hoffmann-La Roche AG (CH) | 2026-04-08 | — | — | EP | claimed |
| EP-3986553-B1 | CYCLOBUTYL CARBOXYLIC ACIDS AS LPA ANTAGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4514794-B1 | FGFR2 INHIBITOR COMPOUNDS | LILLY CO ELI (US) | 2026-03-25 | — | — | EP | claimed |
| EP-0854899-B1 | FLUORINE-SUBSTITUTED ALKENYL LIQUID CRYSTALLINE COMPOUNDS | CHISSO CORP (JP) | 2001-01-10 | — | — | EP | claimed |
| EP-0805134-B1 | NOVEL LIQUID-CRYSTAL COMPOUNDS BEARING DIENYL MOIETY AND LIQUID-CRYSTAL COMPOSITION | CHISSO CORP (JP) | 2000-08-30 | — | — | EP | claimed |
| EP-0987238-A1 | LIQUID-CRYSTALLINE COMPOUNDS HAVING BICYCLO 1.1.1]PENTANE STRUCTURE, LIQUID-CRYSTAL COMPOSITION, AND LIQUID-CRYSTAL DISPLAY ELEMENT | CHISSO CORPORATION (JP) | 2000-03-22 | — | — | EP | claimed |
| EP-0976703-A1 | LIQUID-CRYSTAL COMPOUNDS, LIQUID-CRYSTAL COMPOSITION CONTAINING THE SAME, AND LIQUID-CRYSTAL DISPLAY ELEMENT CONTAINING THE SAME | CHISSO CORPORATION (JP) | 2000-02-02 | — | — | EP | claimed |
| EP-0805134-A1 | NOVEL LIQUID-CRYSTAL COMPOUNDS BEARING DIENYL MOIETY AND LIQUID-CRYSTAL COMPOSITION | CHISSO CORPORATION (JP) | 1997-11-05 | — | — | EP | claimed |
| EP-0735015-A2 | A liquid crystal compound having (a) deuterium atom (s) and a liquid crystal composition comprising the said compound | CHISSO CORPORATION (JP) | 1996-10-02 | — | — | EP | claimed |
| US-5405550-A | Molecular building beams, liquid crystals and surfactants | Michl, Josef (US) | 1995-04-11 | — | — | US | claimed |
| EP-0449831-A4 | COMPOUNDS AND METHODS BASED ON 1.1.1)PROPELLANE | — | 1992-05-20 | — | — | EP | claimed |
| EP-0449831-A1 | COMPOUNDS AND METHODS BASED ON 1.1.1]PROPELLANE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-10-09 | — | — | EP | claimed |
| WO-1989012085-A1 | COMPOUNDS AND METHODS BASED ON [1.1.1]PROPELLANE | THE UNIVERSITY OF TEXAS SYSTEM (US) | 1989-12-14 | — | — | WO | claimed |